You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chemoembolization

Showing 1 - 25 of 671
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CT Imaging for Guiding PA-TACE for HCC

Recruiting
  • Carcinoma, Hepatocellular
  • postoperative adjuvant transarterial chemoembolization
  • Guangzhou, Guangdong, China
    ZhuJiang Hospital of Southern Medical University
Nov 30, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Bevacizumab combined with Sintilimab, Transcatheter arterial chemoembolization)

Recruiting
  • Hepatocellular Carcinoma
  • Bevacizumab combined with Sintilimab
  • Transcatheter arterial chemoembolization
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Oct 14, 2023

HepaSphere Transarterial Chemoembolization Combined With Hepatic

Not yet recruiting
  • Colorectal Liver Metastases (CRCLM)
  • DEB-TACE plus HAIC
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 25, 2023

Hepatocellular Carcinoma Trial (TACE(transcatheter arterial chemoembolization), lenvatinib, Icaritin soft capsules)

Not yet recruiting
  • Hepatocellular Carcinoma
  • TACE（transcatheter arterial chemoembolization）
  • +2 more
  • (no location specified)
Jun 5, 2023

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Nanjing (Oxycodone, Sufentanil)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 15, 2023

Hepatocellular Carcinoma Trial in New York (SBRT, TACE)

Completed
  • Hepatocellular Carcinoma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 22, 2022

Patterns of Transcatheter Arterial Chemoembolization Combined

Not yet recruiting
  • HCC
  • (no location specified)
Aug 29, 2023

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Hepatocellular Carcinoma Trial in Nanning (Transarterial chemoembolization, Radiotherapy)

Recruiting
  • Hepatocellular Carcinoma
  • Transarterial chemoembolization
  • Radiotherapy
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 25, 2023

Antibiotic Prophylaxis Trial in Lahore (Ceftriaxone Sodium)

Recruiting
  • Antibiotic Prophylaxis
  • Ceftriaxone Sodium
  • Lahore, Punjab, Pakistan
    Pakistan Kidney and Liver Institute
Dec 8, 2022

Hepatocellular Carcinoma, Transcatheter Arterial ChEmoembolization, Regorafenib Trial in Guangzhou (TACE, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    FirstSunYetSen
Apr 12, 2023

Hepatocellular Carcinoma Trial in New Delhi (N Acetylcysteine, Dexamethasone, Placebo)

Not yet recruiting
  • Hepatocellular Carcinoma
  • N Acetylcysteine
  • +2 more
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Sep 8, 2023

Gastric Cancer, Embolization Trial (Transarterial Chemoembolization)

Not yet recruiting
  • Gastric Cancer
  • Embolization
  • Transarterial Chemoembolization
  • (no location specified)
May 17, 2022

Tislelizumab, Lenvatinib, TACE Trial in Nanning (Tislelizumab and Lenvatinib)

Active, not recruiting
  • Tislelizumab
  • +3 more
  • Tislelizumab and Lenvatinib
  • Nanning, Guangxi, China
    The Affiliated Cancer Hospital of Guangxi Medical University
Jan 25, 2023

NSCLC Trial in Zhengzhou (Tislelizumab)

Active, not recruiting
  • NSCLC
  • Zhengzhou, Hennan, China
    The First Affiliated Hospital of Zhengzhou University
Oct 31, 2022

Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma Trial in Palo Alto, Sapporo (radiation, procedure,

Active, not recruiting
  • Child-Pugh Class A
  • +2 more
  • Stereotactic Body Radiation Therapy
  • +3 more
  • Palo Alto, California
  • +1 more
Sep 9, 2022

Hepatocellular Carcinoma Trial (Donafenib, TACE)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 8, 2022

Lung Non-Small Cell Carcinoma, Mediastinal Tumor, Pleural Tumor Trial in Duarte (Angiography, Computed Tomography, Ethiodized

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +2 more
  • Angiography
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022

Hepatocellular Carcinoma, Bilirubinemia Trial in Minneapolis (Transarterial chemoembolization)

Completed
  • Hepatocellular Carcinoma
  • Bilirubinemia
  • Transarterial chemoembolization
  • Minneapolis, Minnesota
    University of Minnesota
Mar 18, 2022

Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of

Recruiting
  • Circulating Tumor DNA
  • +2 more
  • DNA
  • Rouen, France
    CHU de Rouen
May 23, 2022

Tumor Micronecrosis on Postoperative Transcatheter Arterial

Completed
  • Carcinoma, Hepatocellular
  • transcatheter arterial chemoembolization
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, Zhejiang University School of Med
Apr 22, 2022

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 20, 2022

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Chongqing (Esketamine, Sufentanil)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jan 2, 2023